Human Genome Sciences, Inc (HGSI)

[High Roller]

Trading Higher on Heavy Volume are Shares of Human Genome Sciences on 1.6x Above-Average Volume (HGSI)
6 hours 32 minutes ago - F82
Financial News Network Online - Unusual VolumeThe price of Human Genome Sciences shares has climbed to $9.67 (a 5.9% change) on heavy trading volume. Approximately 9.8 million shares have changed hands today vs. average 30-day volume of 6.2 million shares. Spikes in volume can validate a breakout or signify a potential turning point. Human Genome Sciences, Inc. researches and develops proprietary pharmaceutical and diagnostic products. The Company's products predict, prevent, detect, treat, and cure disease based on the discovery of human and microbial genes. Human Genome Sciences has overhead space with shares priced $9.67, or 49.9% below the average consensus analyst price target of $19.31. Human Genome Sciences shares should encounter resistance at the 200-day moving average (MA) of $16.79 and support at the 50-day MA of $7.84. Over the past year, Human Genome Sciences has traded in a range of $6.51 to $30.15 and is now at $9.67, 49% above that low. The 200-day and 50-day moving averages have moved 1.64% lower and 0.49% lower over the past week, respectively. --------------------------------------------------------------------------------------------- Financial News Network Online (FNNO) is a leading provider of digital financial news content for distribution on the web. You can count on FNNO to bring you the latest market news, earnings reports, analyst comments, economic data reports and more. Visit http://www.fnno.com today.